Oricula Therapeutics, a Seattle-based biotech, has received FDA clearance to begin volunteer human testing for their investigational drug ORC-13661. ORC-13661 is being studied for its potential to preserve hearing by protecting the ear hair cells of patients taking antibiotics known to cause hearing damage. The human testing will evaluate the safety, tolerability, and the movement… Continue reading Investigational Hearing Protection Drug Given FDA Clearance for Human Testing